Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 5/20 | 0.44 |
| ▸ | ACHE | P22303 | 5/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 5/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MPO | P05164 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7424524 | 0.85 | CYP2C19 (0.49) | CYP2C19KDM4ECYP3A4HIF1ARXFP1 | |
| SCHEMBL2799868 | 0.84 | LMNA (0.52) | CYP2C19KDM4ECYP3A4HIF1ARXFP1 | |
| SCHEMBL2538787 | 0.81 | KDM4E (0.66) | CYP2C19KDM4ECYP3A4HIF1AHTT | |
| SCHEMBL15724648 | 0.81 | CYP1A2 (0.57) | CYP2C19KDM4ERXFP1CYP1A2CYP2D6 | |
| SCHEMBL30048942 | 0.81 | CYP1A2 (0.57) | CYP2C19KDM4ERXFP1CYP1A2CYP2D6 | |
| SCHEMBL2538783 | 0.81 | KDM4E (0.66) | CYP2C19KDM4ECYP3A4HIF1ABCHE | |
| SCHEMBL4015829 | 0.81 | NT5E (0.64) | CYP2C19KDM4ECYP3A4HIF1ARXFP1 | |
| SCHEMBL31218411 | 0.81 | NT5E (0.64) | CYP2C19KDM4ECYP3A4HIF1ARXFP1 | |
| SCHEMBL5910832 | 0.78 | KDM4E (0.62) | CYP2C19KDM4ECYP3A4HIF1AACHE | |
| SCHEMBL2534941 | 0.78 | KDM4E (0.62) | CYP2C19KDM4ECYP3A4HIF1ABCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11242957-B2 | Kinetic hydrate inhibitors for controlling gas hydrate formation in wet gas systems | CHAMPIONX USA INC. (US) | 2022-02-08 | — | — | US | claimed |
| US-20190353307-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | HARBISON-FISCHER, INC. | 2019-11-21 | — | — | US | claimed |
| EP-3420055-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | Ecolab USA Inc. (US) | 2019-01-02 | — | — | EP | claimed |
| WO-2017147426-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | ECOLAB USA INC. (US) | 2017-08-31 | — | — | WO | claimed |
| US-20170248276-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | US SYNTHETIC CORPORATION | 2017-08-31 | — | — | US | claimed |
| EP-3420055-B1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | CHAMPIONX LLC (US) | 2025-04-09 | — | — | EP | disclosed |
| US-20230226062-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | INCYTE CORPORATION | 2023-07-20 | — | — | US | disclosed |
| US-11242957-B2 | Kinetic hydrate inhibitors for controlling gas hydrate formation in wet gas systems | CHAMPIONX USA INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-20190353307-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | HARBISON-FISCHER, INC. | 2019-11-21 | — | — | US | disclosed |
| US-10393319-B2 | Kinetic hydrate inhibitors for controlling gas hydrate formation in wet gas systems | ECOLAB USA INC. (US) | 2019-08-27 | — | — | US | disclosed |
| EP-3420055-A1 | KINETIC HYDRATE INHIBITORS FOR CONTROLLING GAS HYDRATE FORMATION IN WET GAS SYSTEMS | Ecolab USA Inc. (US) | 2019-01-02 | — | — | EP | disclosed |
| WO-2018119263-A1 | HETEROCYCLIC COMPOUNDS DERIVATIVES AS PD-L1 INTERNALIZATION INDUCERS | INCYTE CORPORATION (US) | 2018-06-28 | — | — | WO | disclosed |
| EP-1737839-A1 | NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING SAID COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-01-03 | — | — | EP | disclosed |
| US-20050267115-A1 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-12-01 | — | — | US | disclosed |
| WO-2005103029-A1 | NOVEL ALKYNE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING SAID COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005103002-A2 | NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-11-03 | — | — | WO | disclosed |
| US-20050234101-A1 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-10-20 | — | — | US | disclosed |
| EP-0096214-B1 | ANTIBACTERIAL PYRIMIDINE COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1991-02-27 | — | — | EP | disclosed |
| US-4587341-A | BACTERICIDES | BURROUGHS WELLCOME CO. (US) | 1986-05-06 | — | — | US | disclosed |
| EP-0096214-A1 | Antibacterial pyrimidine compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1983-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050267115-A1 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | MCHR1, GPR119, MCHR2 | CYP2C19 3638/4885KDM4E 1952/4885CYP3A4 3589/4885 |
| US-20050234101-A1 | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds | MCHR1, GPR119, MCHR2 | CYP2C19 3999/4885KDM4E 2256/4885CYP3A4 3608/4885 |
| US-20230226062-A1 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | CD274, PDCD1, PDCD1LG2 | CYP2C19 1322/4885KDM4E 1970/4885CYP3A4 1652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.